President Donald Trump has called on health officials to speed up efforts to import drugs from Canada. The Department of Health and Human Services started taking steps to allow importation in July. Canadian officials oppose the plan, saying it could cause shortages and drive up costs in the country. (Reuters)

Drug companies have reached a $260 million settlement to avoid an opioid trial. Three drug distributors and one pharmaceutical company reached last-minute settlements to avoid going to trial in Ohio. These deals have left Walgreens as the only defendant in the case brought by two Ohio counties, delaying the case. (MM&M)

The last-minute deal could be a step toward settling all 2,500 U.S. opioid-related lawsuits, according to lawyers for the plaintiffs in those cases. A settlement for all federal opioid cases would likely reach several billion dollars. These negotiations will likely resume with the Ohio case delayed. (Wall Street Journal)

A judge has allowed Massachusetts’ four-month vaping ban to continue. Several vape shops and a vaping industry group have challenged the ban, which was put into place in response to teen vaping and the vaping-related lung illness, but the judge said that lifting the ban “would contravene the public interest.” (Associated Press)

Seattle Genetics is seeing positive results in a late-stage breast cancer trial. The trial showed delayed tumor growth and improved survival in patients who took Seattle’s experimental breast cancer pill. The company is set to file a new drug application early next year. (STAT)